YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
cbdMD, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.35−0.01 (-2.22%)
Close on Oct 19, 2026
- Market cap
- $3.70M
- P/E (TTM)
- –
- Dividend yield
- –
cbdMD, Inc. revenue by segment
By business segment
| Revenue | Q2 22 | Q4 21 | Q3 21 | Q2 21 | Q1 21 | Q4 20 | Q3 20 | Q2 20 | Q1 20 | Q4 19 | Q3 19 | Q2 19 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Licensing Division | – | – | – | – | – | – | – | – | – | – | $3.35K | $5.19K | – | – |
| Entertainment Division | – | – | – | – | – | – | – | – | – | – | $20.11K | $20.61K | – | – |
| Professional Product Division | – | – | – | – | – | – | – | – | – | – | $8.02M | $5.65M | – | – |
By product or service
| Revenue | Q2 22 | Q4 21 | Q3 21 | Q2 21 | Q1 21 | Q4 20 | Q3 20 | Q2 20 | Q1 20 | Q4 19 | Q3 19 | Q2 19 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E-commerce Sales | $6.58M | $7.27M | $7.82M | $8.36M | $9.70M | $8.51M | $8.23M | $6.78M | $6.86M | – | – | – | 68.3% | -21.3% |
| Wholesale Sales | $3.05M | $2.52M | $2.74M | $3.44M | $2.63M | $3.14M | $2.41M | $2.62M | $3.28M | – | – | – | 31.7% | -11.3% |
| Consumer Product Sales | – | – | – | – | – | $8.51M | $8.23M | $6.78M | $6.86M | $5.41M | $4.64M | $4.26M | – | – |
| Service Related Sales | – | – | – | – | – | – | $0 | $0 | $0 | $0 | $0 | $0 | – | – |
| Wholesale Product Sales | – | – | – | – | – | $3.14M | $2.41M | $2.62M | $3.28M | $4.14M | $3.37M | $1.38M | – | – |
By region
From the segment and revenue-disaggregation notes of cbdMD's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.